Question 1

What is Eyepoint Pharmaceuticals Inc (EYPT) stock price today?

Accepted Answer

Eyepoint Pharmaceuticals Inc (EYPT) currently trades at $13.20 per share. The stock has a market capitalization of $1.08B and a P/E ratio of —x.

Question 2

Is EYPT stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Eyepoint Pharmaceuticals Inc has a Smart Value Score of 33/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Eyepoint Pharmaceuticals Inc's revenue and earnings?

Accepted Answer

Eyepoint Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $31.37M with profit margins of 0.00%. Earnings per share (EPS) is $-3.17.

Question 4

Is EYPT stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Eyepoint Pharmaceuticals Inc's intrinsic value is $20.71, representing a margin of safety of 37.95%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$41.40M	$46.02M	$43.27M	$31.37M	$31.37M
Net income	$-102.25M	$-70.80M	$-130.87M	$-231.96M	$-67.61M
EPS	—	—	—	—	$-3.17
Free cash flow	$-67.16M	$-1.61M	$-130.28M	$-243.39M	$-66.03M
Profit margin	-246.97%	-153.84%	-302.43%	-739.42%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
EYPT	$1.08B	33	5.3	2.5	6.7	5.0	+37.95%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Eyepoint Pharmaceuticals Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare